Tevogen Bio Holdings (TVGN) Shareholder's Equity (2021 - 2026)

Tevogen Bio Holdings (TVGN) Shareholder's Equity (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 7.14 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 795.79 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 595,226.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - 502.95 Mn
10 Tevogen Bio Holdings 182.04 Mn 181.35 Mn - -9.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.84 Mn
Dec 31, 2025 -8.23 Mn
Sep 30, 2025 -7.82 Mn
Jun 30, 2025 -9.48 Mn
Mar 31, 2025 -7.72 Mn
Dec 31, 2024 -6.67 Mn
Sep 30, 2024 -6.19 Mn
Jun 30, 2024 -7.66 Mn
Mar 31, 2024 -5.80 Mn
Dec 31, 2023 -94.43 Mn
Sep 30, 2023 -90.80 Mn
Jun 30, 2023 -86.89 Mn
Mar 31, 2023 -64.71 Mn
Dec 31, 2022 -33.95 Mn
Sep 30, 2022 -14.66 Mn
Jun 30, 2022 -14.05 Mn
Mar 31, 2022 -14.25 Mn
Dec 31, 2021 -14.23 Mn